Ascendis Pharma A/S (ASND)
241.70
-8.14
(-3.26%)
USD |
NASDAQ |
Apr 15, 16:00
241.70
0.00 (0.00%)
After-Hours: 18:28
Ascendis Pharma Research and Development Expense (Annual) : 333.10M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Novo Nordisk A/S | 6.838B |
| Evaxion AS | 9.691M |
| DBV Technologies SA | 107.12M |
| Biodexa Pharmaceuticals Plc | 5.026M |
| Trinity Biotech Plc | 4.535M |